In Brief Secretin, a gut hormone secreted while eating a meal, stimulates brown fat thermogenesis and induction of satiation in mice and humans. Li et al., 2018 , Cell 175, 1561-1574 November 29, 2018 
INTRODUCTION
In mammals, white adipose tissue (WAT) stores fat as the major energy backup for times of limited food supply, whereas brown adipose tissue (BAT) generates heat in response to cold exposure (Rosen and Spiegelman, 2006) . Thermogenesis in BAT, known as non-shivering thermogenesis, dissipates chemical energy of nutrients by uncoupling oxygen consumption from ATP synthesis in mitochondria (Klingenspor, 2003) . This mechanism depends on the uncoupling protein 1 (UCP1). Cold exposure activates BAT and leads to the recruitment of thermogenic capacity (Cannon and Nedergaard, 2004) .
The discovery of cold-induced BAT activity in adult humans, attenuated with age, insulin resistance, diabetes, and obesity, has attained large interest (Sidossis and Kajimura, 2015) . Cold acclimation recruits BAT activity (Blondin et al., 2014; van der Lans et al., 2013) and improves insulin sensitivity (Chondronikola et al., 2014; Hanssen et al., 2015) , body fat mass (Yoneshiro et al., 2013) , and hypercholesterinemia (Berbé e et al., 2015) . It is unclear, however, whether the total catabolic capacity of BAT is sufficient to account for these beneficial metabolic effects (Blondin et al., 2017; Hanssen et al., 2015) .
BAT also contributes to meal-associated thermogenesis (Glick et al., 1981; Saito, 2013; U Din et al., 2018; Vosselman et al., 2013) and to long-term diet-induced thermogenesis (Rothwell and Stock, 1979) . Meal-associated thermogenesis, when regarding a single meal, maybe divided into three phases: a pre-prandial, a prandial, and a postprandial phase. The contribution of BAT thermogenesis to these three phases is unclear. Furthermore, the molecular mediators and functional significance of meal-associated BAT thermogenesis are poorly understood. It is generally believed that an increased periprandial tone of the sympathetic nervous system (SNS) stimulates norepinephrine release from sympathetic nerves in BAT and activates canonical cAMP-PKA (cyclic AMP-protein kinase A) signaling via b3-adrenergic receptors (b3-ARs). This pathway activates lipolysis, UCP1, and non-shivering thermogenesis (Cannon and Nedergaard, 2004) . Notably, meal-associated thermogenesis in BAT may promote central perception of satiation (Blessing et al., 2013; Brobeck, 1948; Glick, 1982; Himms-Hagen, 1995) . In fasted mice, acute pharmacological BAT activation with a b3-AR agonist reduces cumulative food intake during refeeding (Grujic et al., 1997; Susulic et al., 1995) .
All macronutrients elicit meal-associated thermogenesis, but only carbohydrate activates the SNS (Glick, 1982; HimmsHagen, 1995; Welle et al., 1981) . Notably, blockade of b-ARs with propranolol does not attenuate the early meal-associated rise in whole-body heat production caused by a carbohydrate meal or a mixed carbohydrate-rich meal (Astrup et al., 1989; Thö rne and Wahren, 1989; Zwillich et al., 1981) . We therefore hypothesized that not only catecholamines but also one of the gut hormones secreted into circulation during a meal may directly activate BAT. Secretion of gut hormones during a meal encodes information on the nutritional status and coordinates gastrointestinal motility and secretion for digestion and resorption, and it also controls the central perception of satiation and satiety in the brain via enteric neuronal afferent and endocrine feedback pathways (Chaudhri et al., 2006) . In addition, periprandial secretion of gut hormones, like cholecystokinin (CCK) and glucagonlike peptide 1 (GLP-1), stimulates the central efferent tone of sympathetic innervation in BAT and thereby activates mealassociated non-shivering thermogenesis (Beiroa et al., 2014; Blouet and Schwartz, 2012) . Furthermore, gut hormones directly modulate triglyceride metabolism in adipocytes. For example, the gut hormone peptide YY (PYY) inhibits lipolysis via Y2R coupled to G i signaling (Valet et al., 1990) , and secretin stimulates lipolysis through the secretin receptor (Sctr) coupled to G s (Braun et al., 2018) . As lipolysis is an essential prerequisite of BAT thermogenesis, we therefore set out to identify gut hormones that directly activate meal-associated thermogenesis in BAT and control satiation.
RESULTS

Abundant Expression of the Secretin Receptor in Brown Adipocytes
In a first step, we profiled gene expression of gut hormone receptors by inquiring transcriptome data obtained from interscapular BAT (iBAT) tissue of mice (GSE119452). Among the detectable transcripts of gut hormone receptor genes in iBAT, the secretin receptor (Sctr) stood out with the highest transcript abundance compared to other gut hormone receptors ( Figure 1A ). Our qPCR analyses revealed that Sctr is more abundantly expressed in iBAT compared to inguinal (iWAT) and epididymal (eWAT) white adipose tissue ( Figure 1B ). Preferential Sctr expression in brown adipocytes was also observed in primary cultures derived from these fat depots ( Figure 1C ). The Online Biology Gene Portal System (BioGPS) also detects Sctr as highly expressed in BAT ( Figure S1 ).
Sctr gene expression predominated in mature brown adipocytes compared to undifferentiated stromal vascular cells (SVF) ( Figure 1D ), and differentiation of brown adipocytes was associated with an increase in Sctr at the transcript (Figure 1E) and at the protein level ( Figure 1F) . SCTR is a G s protein-coupled GPCR (G-protein-coupled receptor) receptor of the class II receptor family (Afroze et al., 2013) . Upon secretin binding, SCTR activates lipolysis by cAMP-PKA signaling in murine white adipocytes (Braun et al., 2018) . In brown adipocytes, free fatty acids released by lipolysis serve as activators of UCP1 and substrates for thermogenesis. Moreover, secretin was reported to stimulate oxygen consumption in rat brown adipocytes (Dicker et al., 1998) . Therefore, we postulated that SCTR in brown adipocytes may activate UCP1-mediated thermogenesis upon binding of secretin.
Secretin Activates Thermogenesis
To test whether secretin can activate thermogenesis, we measured UCP1-mediated thermogenesis in cultured adherent primary brown adipocytes (Li et al., 2014) . We observed that secretin at a 50-fold lower concentration is as potent as isoproterenol (ISO), a b-AR agonist, in stimulating thermogenesis (Figures 2A and 2B) . The minimal concentration to stimulate thermogenesis in brown adipocytes was 0.1 nM for secretin ( Figure S2A ) but at least 10 nM for ISO ( Figure S2B ). In doseresponse experiments, EC 50 values for secretin and ISO were 0.13 nM and 23.4 nM, respectively ( Figure S2C ). The thermogenic effect of secretin was independent of ARs, since pretreatment of brown adipocytes with propranolol, a nonselective b-AR antagonist, did not attenuate secretin-stimulated respiration while blocking the effect of ISO in a dose-dependent manner ( Figure 2C ). The thermogenic effect of secretin, however, depends on SCTR, as small interfering RNA (siRNA)-mediated downregulation of receptor expression ( Figure S2G ) blunted the effects of secretin on oxygen consumption ( Figure 2D ). Secretin stimulation resulted in a dose-dependent increase of relative cytosolic cAMP levels in brown adipocytes ( Figure S2D ). Pretreatment of cells with H89, a selective inhibitor of PKA (Figure 2E) , or inhibitors targeting the two key lipases involved in lipolysis (adipose triglyceride lipase, ATGL; hormone-sensitive lipase, HSL), completely blocked the thermogenic effect of secretin ( Figure 2F ). This demonstrates that secretin-induced thermogenesis depends on the activation of lipolysis through the canonical cAMP-PKA pathway. Secretin also increased thermogenic gene expression in brown and white adipocytes (Figures S2E and S2F) . Together, these data reveal a novel physiological role of secretin, serving as a non-adrenergic activator of thermogenesis.
We next tested whether secretin could induce thermogenesis in vivo using indirect calorimetry. A single intraperitoneal (i.p.) injection of secretin increased heat production in wild-type (WT) mice but not in UCP1 knockout (KO) mice ( Figures 2G-2I) . The thermogenic secretin effect in WT mice was maintained at thermoneutrality (TN, 30 C) , and the magnitude is comparable to noradrenaline ( Figures 2J and 2K ), which was confirmed by a corresponding rise in iBAT temperature ( Figure 2L ). To further visualize BAT activation, we applied indirect calorimetry with multispectral optoacoustic tomography (MSOT) in nude mice, which detects the spectra of oxygenated and deoxygenated hemoglobin in high resolution deep in tissues and blood vessels (Reber et al., 2018) . By monitoring the Sulzer's vein, the only venous drainage of iBAT, we found that total blood volume (TBV) was increased whereas relative oxygen saturation (SO 2 ) was dramatically decreased after secretin stimulation ( Figures  2M-2P ). Thus, secretin activates iBAT thermogenesis in vivo.
Secretin-Activated BAT Induces Satiation Plasma secretin levels were decreased by fasting (18 hr) and increased significantly within 1 hr after refeeding ( Figure 3A) , which is congruent with changes of iBAT temperature ( Figure 3B ).
The periprandial rise of secretin may suppress food consumption, as peripheral and central administration of secretin reduces food intake in fasted mice depending on the presence of the SCTR (Cheng et al., 2011) . Integrated with our present finding, we hypothesized that secretin inhibits food intake through activation of BAT. To test this hypothesis, fasted mice were injected with 5 nmol secretin before refeeding. Secretin reduced food intake compared with PBS-injected mice ( Figure 3C ) during the first 2-3 hr of refeeding, possibly due to the short half-life of secretin (Curtis et al., 1976) .
To further explore whether the reduction in food intake was dependent on BAT thermogenesis, we compared the effect of secretin on food intake in UCP1 WT and KO mice. Remarkably, the inhibitory effect of secretin on food intake was attenuated in UCP1-KO mice ( Figures 3D and 3E) . Therefore, we conclude that secretin-induced thermogenesis in BAT accelerates satiation during the first bouts of refeeding. This satiation effect could be mediated either by direct activation of BAT or by central effects of secretin activating the sympathetic output to BAT. In contrast to the effect of b3-AR agonist CL-316,243 (CL), the effects of secretin on food intake ( Figures 3F-3H ) and BAT temperature ( Figures 3I-3P) , however, were retained in mice pretreated with propranolol. Therefore, secretin directly activates BAT independent of the efferent sympathetic innervation. Consistent with previous findings (Grujic et al., 1997; Susulic et al., 1995) , BAT activation by adrenergic signaling (CL) also leads to a suppression of appetite, which indicates that satiation is a general consequence of BAT thermogenesis. Moreover, our data also demonstrate that BAT plays a negligible role in pre-prandial thermogenesis ( Figure S3A ). While prandial thermogenesis and early postprandial thermogenesis do not depend on adrenergic signaling, as propranolol failed to block the increase (A) Profiling of gut hormone receptors expressed in murine brown adipose tissue (BAT) using RNA sequencing (RNA-seq) data. Data are shown as RPKM (reads per kilobase per million mapped reads). Secretin receptor (Sctr) stood out with the highest transcript abundance compared to other gut hormone receptors such as gastric inhibitory polypeptide receptor (Gipr), vasoactive intestinal peptide receptor1/2 (Vipr1/2), cholecystokinin A/B receptor (Ccka/br), ghrelin receptor (Ghsr), glucagon-like peptide 1 receptor (Glp1r), and the PYY 3-36 receptor (Npy2r) (n = 4). (B and C) Relative expression levels of Sctr in BAT and inguinal (iWAT) and epididymal (eWAT) white adipose tissues as well as primary cultures (C) derived from these fat depots assessed by qPCR (n = 5). (D) Relative expression abundance of Sctr, Pref1 (preadipocyte factor 1), and aP2 (adipocyte protein 2) in stromal vascular fraction (SVF) and mature adipocytes (n = 3). (E) Time course expression of uncoupling protein 1 (Ucp1) and Sctr mRNA during brown adipocyte differentiation (n = 3). (F) Western blot analysis of SCTR, UCP1, and b-actin in both SVF and differentiated brown adipocytes. Data are presented as means ± SD. (B) Repeated-measures one-way ANOVA (Tukey's test), (C) one-way ANOVA (Tukey's test), (D) unpaired t test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001. See also Figure S1 .
in BAT temperature induced by refeeding, late postprandial thermogenesis depends on adrenergic signaling (Figures S3A and S3B) . This is consistent with the previous finding that the most pronounced effect of b-blockade on postprandial energy expenditure was found 3-4 hr after the meal (Astrup et al., 1989) . We next investigated the neurobiological basis of satiation induced by secretin-activated BAT. We found that secretin treatment elevated anorexigenic proopiomelanocortin (POMC) and repressed orexigenic agouti-related protein (AgRP) mRNA levels in the hypothalamus of fasted mice in an UCP1-dependent manner ( Figures 3Q-3S ). There was no effect of secretin on cocaine-and amphetamine-regulated transcript (CART) and neuropeptide Y (NPY) transcript levels ( Figures S3C-S3E) . Moreover, the expression of transient receptor potential vanilloid 1 (TRPV1), a temperature-sensitive ion channel expressed in POMC neurons, was upregulated by secretin treatment in the hypothalamus of WT but not in UCP1-KO mice ( Figure 3T ). Activation of TRPV1-like receptors in POMC neurons of the hypothalamic arcuate nucleus by warm temperature leads to appetite suppression (Jeong et al., 2018) . Thus, our data support the idea that the TRPV1 receptor senses the rise in hypothalamic temperature due to BAT-mediated meal-associated prandial thermogenesis and activates the POMC neurons (Rampone and Reynolds, 1991) . Congruently, we found that short-term heat exposure regulated neuropeptides and TRPV1 gene expression in a similar pattern as secretin treatment (Figures S3F and S3G) . Together, these results suggest that the satiation signal emanating from secretin-activated BAT was sensed in the brain and promoted satiation, likely through perception of heat generated by BAT.
To further emphasize the strong relationship between BAT thermogenesis and food intake, we performed an analysis of around 2,000 food intake events in 23 mice during 70 hr (ad libitum feeding) when BAT temperature was recorded simultaneously using implanted transmitters. Our analysis showed that (1) the initiation of feeding is always accompanied by a rise in iBAT temperature and that (2) the peak of iBAT temperature is followed by termination of feeding ( Figures S3H-S3K ). Therefore, a rise in iBAT temperature was plausibly the consequence of food intake and subsequently could have caused the termination of feeding. In short, thermogenic BAT plays an important role in the acute control of food intake in mice. Consistently, UCP1-KO mice showed dramatic alterations in feeding behavior with decreased number of meals, increased meal size and meal duration, and decreased inter-meal bout length, whereas total food intake was similar to WT mice . Taken together, secretin inhibits food intake through directly activating BAT thermogenesis and thereby conveys an unappreciated function of BAT in the control of satiation.
Neutralizing Prandial Secretin Activity Blunts MealAssociated Thermogenesis, Increases Food Intake, and Changes Meal Patterning Based on the thermogenic effects of exogenous secretin, we reasoned that endogenous release of secretin during refeeding stimulates prandial thermogenesis in BAT. A polyclonal secretin antibody was applied to neutralize the endogenous activity of secretin. This antibody completely neutralized purified secretin as well as endogenous blood-borne secretin mediated activation of SCTR signaling when tested in vitro ( Figure S5 ). Refeeding of fasted mice was associated with an immediate rise in iBAT temperature by $2 C within 30 min ( Figure 4A ). Compared to mice treated with isotype-like anti-GFP antibody, this rise in iBAT temperature was largely attenuated in mice pretreated with the secretin antibody ( Figures 4A and 4B ). The antibody also increased food intake during the early phase of refeeding BMR and heat production upon stimulation were quantified as area under the curve (AUC) (I) (n = 6-9).
(J-L) The thermogenic effects of secretin (5 nmol), noradrenalin (1 mg/kg), and PBS on mice acclimatized for 1 week to thermoneutrality (30 C). Heat production was determined by the same procedure as for mice kept at room temperature. Additionally, the temperature of interscapular brown adipose tissue was recorded via implanted E-mitter (L). ( Figures 4C-4E ). Detailed analysis revealed a negative correlation between the rise in iBAT temperature and food intake (Figure 4F) . Thus, secretin released endogenously in response to food intake is a physiological mediator of meal-associated thermogenesis in BAT, and the induction of BAT thermogenesis is necessary for the inhibitory effect of secretin on food intake. Our findings demonstrate a novel endocrine gut-secretin-BATbrain axis in the acute control of food intake. Analyzing the feeding behavior of WT mice treated with the secretin antibody under ad libitum feeding conditions, we found that these WT mice phenocopied the UCP1-KO mice by showing increased meal sizes as well as longer meal durations ( Figures  4G-4K ). Therefore, disruption of the gut-BAT-brain axis in the control of satiation by blocking endogenous secretin activity alters feeding behavior. We thereby recapitulate our findings in a WT mouse model with acute loss of secretin function that is not subject to long-term adaptive responses due to genetic ablation as may be prevalent in germline UCP1-KO.
Secretin Infusion Transiently Elevates Energy
Expenditure in Diet-Induced Obese Mice Secretin promoted negative energy balance through both increasing energy expenditure and decreasing energy intake and therefore may hold promise for developing novel obesity therapies. To clarify the potential therapeutic uses, we chronically infused diet-induced obese mice (DIO) with native human secretin (native secretin) and a modified human secretin analog (modified secretin), respectively. In a first experiment conducted with DIO mice kept at room temperature (RT), the modified secretin caused a small transient reduction in cumulative food intake ( Figure S6A ) and body weight gain ( Figure S6B ). After 2 weeks of treatment, body fat mass was slightly lower in modified-secretin-treated mice. This was not reflected by a lower body mass as the lean mass was slightly increased in these mice ( Figure S6C ). Compared to GLP-1 as a positive control, these effects were minor. Employing a linear mixed effects model to test whether secretin also affects metabolic rate, we found that the small effect of secretin on food intake was not alone explained by the starting body weight (which captures the metabolic requirements of the animal) and the change in body weight (which primarily captures the alternate fate of food: fat deposition loss), suggesting that the modified secretin modulated metabolic rate.
Effects on energy expenditure at RT may be masked, as this thermal environment already imposes a cold challenge on mice and activates thermoregulatory heat production, mainly in BAT, as exemplified by a nearly 2-fold increase of resting metabolic rate by transfer from 30 C to 20 C (Fischer et al., 2018) . Therefore, we conducted a second experiment to directly measure whether chronic infusion of the modified secretin increases energy expenditure analyzed as heat production in DIO mice kept at TN. On days 1 and 2 after start of infusion, the modified secretin led to a transient increase in daily energy expenditure by 32% and 9%, respectively ( Figures 5A-5C ). No such effect on energy expenditure was observed in control mice infused with native secretin, or with the GLP-1 analog. The GLP-1 analog induced a pronounced decrease in food intake and body fatness, whereas the minor effects of the modified secretin on body composition observed at RT were not observed at TN (Figures 5D -5F). We conclude that the transient increase in energy expenditure after onset of chronic infusion of the human secretin analog strongly promoted negative energy balance in DIO mice even when kept at TN. Notably, mice infused with the modified secretin at TN showed a significant increase in water intake most likely to compensate for increased water secretion by the pancreas ( Figure 5G ).
These data demonstrate thermogenic activity of secretin also in DIO mice but rather discourage the application of chronically elevated secretin levels as a therapeutical option for the treatment of obesity. Secretin Activates Human BAT We addressed the biological significance of thermogenic action of secretin in humans. For this purpose, secretin concentrations were measured in serum samples from human subjects showing BAT activation in response to a single meal, as reported very recently (U Din et al., 2018) . Consistent with our observations in mice, serum secretin levels increased after single-meal ingestion ( Figure 6A ). The increment of plasma secretin levels induced by a single meal positively correlated with postprandial oxygen consumption rates and fatty acid uptake rates in BAT (Figures 6B and 6C) . Direct evidence for the thermogenic action of secretin in BAT was obtained by FDG-PET-CT scans after two secretin infusions that significantly increased serum secretin level ( Figure S6D ) and glucose uptake in human BAT compared to placebo control treatment ( Figure 6D ). Collectively, we propose that the satiation axis sparked by BAT activation through secretin is conserved from mouse to man.
DISCUSSION
Thermogenesis in brown adipose tissue, contributing to mealassociated thermogenesis (or diet-induced thermogenesis) and cold-induced non-shivering thermogenesis, is generally believed to be switched on by noradrenaline released from sympathetic nerve endings. In this study, we identified that the gut hormone secretin, upon release during eating, serves as a novel non-sympathetic BAT activator mediating prandial thermogenesis, which consequentially induces satiation. We thereby reveal a gut-secretin-BAT-brain axis in mammals that constitutes the physiological basis of prandial thermogenesis in the control of satiation. Establishing a largely unappreciated function of BAT in the control of hunger and satiation qualifies BAT as an even more attractive target for treating obesity. Demonstration of a non-canonical gut-secretin-BATbrain axis beyond the canonical gut-brain-BAT axis uncovers (G-K) Feeding behavior of ad libitum-fed mice treated with either secretin antibody of GFP antibody. Total food intake (G), number of meals (H), mean meal size (I), mean meal duration (J), and mean inter-meal bout length (K) of GFP-or secretin-antibody-treated 129S6/SvEv mice during one dark phase. The analysis was performed 2 days after the antibody injection to minimize previous fasting effects (n = 6). Data are presented as means ± SD or individual values. (D and G-K) Unpaired t test, (B and E) paired t test. * = p < 0.05, ** = p < 0.01, *** = p < 0.001. See also Figure S5 .
a yet unknown facet of the complex regulatory system controlling energy balance.
Secretin, an Old Dog Playing a New Trick
Secretin was the first hormone discovered and laid grounds for the conceptual framework of endocrine regulation (Bayliss and Starling, 1902) . It stimulates water and bicarbonate secretion from pancreas to ensure a proper milieu for digestion and absorption of macronutrients and inhibits gastric emptying. Beyond these well-characterized gastrointestinal functions, secretin exhibits metabolic control functions, such as stimulation of lipolysis in white adipocytes (Sekar and Chow, 2014b) and inhibition of food intake (Cheng et al., 2011) . The latter anorexigenic action of secretin was reported to depend on the activation of secretin receptors in vagal sensory nerves and melanocortin signaling in the brain (Cheng et al., 2011; Chu et al., 2013) . Our study demonstrates that secretin, upon release during eating, directly activates BAT thermogenesis. Secretin executes this thermogenic action by signaling via secretin receptors abundantly expressed in brown adipocytes. The BAT activation function of secretin is conserved in human. This BAT activation by secretin is essential for the acute satiating effect of secretin. This link between secretin-induced BAT thermogenesis and satiation is underlined by the observed negative correlation of food intake and meal-associated rise in iBAT temperature. We thereby assign a new metabolic control function to secretin as an endocrine activator of prandial thermogenesis in BAT. We propose that the nutritional status encoded by the meal-induced rise in blood secretin levels is directly transformed into thermogenic activity of BAT, which relays this information to the brain and promotes satiation. This establishes a yet unknown endocrine gut-secretin-BATbrain axis with major implications for integrative energy balance physiology. Secretin as an Endocrine Mediator of Meal-Associated Thermogenesis Meal-associated thermogenesis consists of two parts, the obligatory metabolic costs of food handling for ingestion, digestion and absorption (handling thermogenesis) and facultative thermogenesis. The existence of the latter is still debated, including source of thermogenesis (BAT dependent or not), functional significance and potential mediators (Cannon and Nedergaard, 2004; Kozak, 2010) . BAT as a heater organ has been suggested as a source for facultative meal-associated thermogenesis (Cannon and Nedergaard, 2004; Kozak, 2010) . The general concept of a gut -brain -BAT axis consisted of gastrointestinal hormones being sensed in the brain, either directly or via neural afferent projections increase SNS activity, and stimulate mealassociated thermogenesis by release of norepinephrine in BAT (Bachman et al., 2002) . A contribution of such postprandial sympathetic activation to meal-associated thermogenesis is not always evident (Welle et al., 1981) . Notably, b-blockade failed to reduce metabolic rate in man during the first 3 hours after a carbohydrate meal (Zwillich et al., 1981) or mixed meal (Thö rne and Wahren, 1989), but exerted a significant effect in the period 3-4 hours after the meal (Astrup et al., 1989) . It thus appears that while sympathetically mediated thermogenesis in the late postprandial phase cannot be ruled out, the prandial and early postprandial rise in energy expenditure is initiated by mechanisms independent of the SNS. Consistent with this notion, we found that secretin, as a non-sympathetic endocrine activator, mediates prandial thermogenesis, which may explain the non-sympathetically mediated meal-associated thermogenesis. In contrast to previous studies, focused on postprandial thermogenesis or diet-induced thermogenesis mediated by the SNS activation in animals exposed to long term cafeteria/high-fat diets, we here examined the prandial rise in thermogenesis by directly monitoring iBAT temperature. This physiological readout is unbiased by the animal activity as observed by indirect calorimetry. Recording BAT temperature demonstrated that onset of refeeding acutely activated BAT thermogenesis and this acute prandial BAT thermogenesis is largely independent of adrenergic signaling. Therefore, our study revealed a previously unappreciated BAT -derived thermogenesis during the prandial phase that functions as a signal to the brain to terminate a meal.
Secretin-Activated Brown Fat Controls Food Intake
Our findings elucidate a novel molecular mechanism for mealassociated thermogenesis with BAT acting as a peripheral communication hub between the gut and the brain. In a physiological context, one may question why BAT dissipates part of the energy ingested during a meal where no extra heat production is necessary for body-temperature regulation. Integrating thermostatic (Brobeck, 1948) and glucostatic (Mayer, 1953) hypotheses, meal-associated thermogenesis in BAT was suggested to play a key role in thermoregulatory feeding (Himms-Hagen, 1995) . However, this concept was not further pursued mostly because the loss of thermogenic function in BAT does not cause hyperphagia in UCP1-KO mice, and the b-blocker propranolol does not increase meal sizes (Cannon and Nedergaard, 2004 ). We here reveal that secretin-induced satiation in fasted mice during refeeding depends on the presence of UCP1 and thus on thermogenic BAT function. If BAT relays information on nutritional status to the brain, we suggest that the meal-associated wasting of nutrient energy in BAT, beyond its role in buffering the overwhelming caloric load during feeding, is an inevitable result of this relay function (the cost of a signal). We therefore propose a physiological function of secretin-mediated prandial thermogenesis in the control of satiation. Further evidence compatible with this proposal is provided by our observation that systemic blockade of secretin function not only attenuated the prandial rise in iBAT temperature but also increased food intake. The effect of secretin on thermogenesis and food intake were absent in UCP1-KO mice. In addition, these mice showed a drastic alteration in meal patterning, with longer bouts of feeding indicating a delayed perception of satiation compared to WT mice. These findings consolidate the existence of a gutsecretin-BAT-brain axis involved in the regulation of satiation. Similar to UCP1-KO mice, secretin and SCTR germline KO mice are not hyperphagic but display normal body weight and food intake (Cheng et al., 2011; Sekar and Chow, 2014a) . Disruption of the proposed gut-secretin-BAT-brain axis in the control of satiation is apparently compensated by other anorexigenic pathways preventing long-term disturbances of energy balance, as exemplified by the mild metabolic phenotypes (eat normally and maintain the same body weight as WT mice) of several gut hormone and gut hormone receptor KO mice, such as ghrelin KO mice, CCK and its receptor KO mice, and GLP-1 and its receptor KO mice, highlighting the extensive compensatory mechanisms occurring in vivo (see review in Strader and Woods [2005] ). However, meal patterning, which is altered in UCP1-KO mice, has not been studied in secretin-and SCTR-deficient mouse models so far. It is highly likely that these germline KO mouse models compensate for increased meal size by initiating fewer meals and thereby maintain body weight due to the interaction between long-term energy homeostasis and meal-related satiation signals. In this scenario, tissue-specific ablation of UCP1, secretin, and SCTR in the adult stage is required to further explore our hypothesis.
Brown Fat Relays Nutritional Status to the Brain
Gut hormones play a critical role in relaying signals of nutritional and energy status from the gut to the central nervous system in order to regulate food intake. Canonically, satiation signals reach the brain either directly via the blood (e.g., amylin and ghrelin) or indirectly by activation of vagal afferent nerves in the intestine (e.g., CCK and GLP-1). In our study, the common satiating effect evoked by secretin and CL indicates that meal termination by BAT-derived heat production is another alternative general mechanism. The hypothalamus and brainstem harbor metabolic sensors, which play a central role in the control of hunger and satiation. Therefore, the meal-termination signal that encodes the nutritional status must be relayed from BAT to the brain. Consistent with this notion, secretin treatment increases anorectic neuropeptide expression in hypothalamic nuclei (Cheng et al., 2011) . Our study further demonstrated that the modulatory effects of secretin on feeding-related neuropeptides were UCP1 dependent, consolidating the essential role of BAT thermogenesis in mediating the satiation effect of secretin. Regarding communication between BAT and said brain regions, it is most likely that a rise in local brain temperature caused by BAT thermogenesis represents the key signal inducing satiation. This view is supported by a classical study demonstrating a rise in temperature in the preoptic hypothalamic area during feeding in rats, where a strong positive correlation was found between the maximal temperature rise in the hypothalamus and the duration of feeding (Abrams and Hammel, 1964) . And there is further evidence that BAT thermogenesis contributes to increases in body and brain temperature under ad libitum condition (Blessing et al., 2013) . A very recent report found a subpopulation of POMC neurons expressing the temperature-sensitive ion channel, TRPV1, which can directly sense local changes in brain temperature. Slight increases in body temperature in response to exercise caused a TRPV1-dependent increase in the activity of POMC neurons, which suppressed feeding in mice (Jeong et al., 2018) . Consistent with this scenario, we discovered that secretin treatment altered Trpv1 transcript abundance in the hypothalamus of WT but not UCP1-KO mice. Despite our data indicating heat as a signal, other possibilities such as neuronal or endocrine mechanisms cannot be excluded. Secretininduced release of adipokines (batokines) or neuronal afferent signaling may alter melanocortin signaling in the hypothalamus. In fact, it has been postulated that afferent sensory nerves in BAT sense the thermal status, blood flow, or intracellular lipolytic products and hence regulate BAT thermogenesis via efferent SNS output (Bartness et al., 2010) . Of note, several hypothalamic nuclei such as the paraventricular nucleus, dorsomedial hypothalamus, and lateral hypothalamus receive sensory inputs from fat depots, pointing toward a sensory feedback mechanism (Ryu et al., 2015) . This alternative or complementary pathway of BAT-brain communication along the gut-secretin-BAT-brain axis is supported by the observation that the anorexigenic action of secretin depends on afferent sensory nerves (Chu et al., 2013) . Further studies are warranted to dissect the contributions of these potential mechanisms. In any case, demonstration of a non-canonical role of BAT in relaying nutritional status to brain beyond the canonical gut-vagal nerve-brain axis uncovers a yet unknown facet of the complex regulatory system that contributes to the termination of feeding.
Meal-Related Satiation Signal and Long-Term Adiposity
Despite the ability of some gastrointestinal hormones such as CCK in previous studies and secretin in our study to reliably reduce meal size when administered prior to a meal, their repeated administration is largely ineffective in reducing food intake and body weight, mainly due to increased feeding frequency to compensate for the suppressed meal size. Thus, orchestration of gut-derived satiation and satiety signals contributes to the maintenance of a relatively constant level of body fat/weight, possibly through interaction with long-term adiposity-related signals (leptin and insulin). This accounted for the negligible effect of chronic secretin infusion to suppress body weight as compared to the pronounced effect of a GLP1 analog with its dual function of both satiation and satiety signal. Indeed, suppression of food intake induced by the GLP-1 analog arises from a combination of reduced meal size and increased inter-meal interval (Williams et al., 2009 ). In murine model systems with ad libitum access to food, gut-hormonebased therapies require targeting both satiation and satiety in an effort to alter energy homeostasis. In a setting closer resembling the human meal pattern, however (i.e., three 30-min meals per day), laboratory rats could not compensate for the satiating effect of the peptide and consequently lost weight (West et al., 1982) . Presence or absence of an altered systemic energy balance thus remains to be determined in man.
Together, these data demonstrate secretin-activated brown fat to be a hub for satiation signaling to reduce meal size and initiate meal termination. Brown adipose tissue thermogenesis thus constitutes a unique target mechanism to manipulate both energy expenditure and energy intake.
Future Perspectives
Research addressing the (patho-) physiological relevance of BAT is concentrating on thermogenesis and the capacity to increase resting metabolic rate. Based on the results of our study, however, the view of BAT as a mere catabolic heater organ must be revised, and more attention needs to be directed toward the function of BAT in the control of hunger and satiation. Several reports demonstrated that glucose and fatty acid uptake in BAT is increased in rodents and humans exposed to a single meal and that maximal thermogenesis coincides with meal termination (Blessing et al., 2013; Glick et al., 1981; U Din et al., 2018; Vosselman et al., 2013) , but there has been a lack of experimental proof for a role of BAT thermogenesis in the control of food intake. According to our data, any stimulus that activates BAT thermogenesis could potentially induce satiation. Targeting this mechanism by nutritional or pharmacological interventions such as enforcing or stimulating the transient meal-associated surge of secretin secretion may provide novel treatment options. In conclusion, we demonstrate that BAT regulates energy intake. Activation of the gut-BAT-brain axis not only increases energy expenditure but also promotes satiation, therefore qualifying this physiological mechanism as an attractive, peripheral target for the treatment of obesity.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
Animal experiments were approved by the German animal welfare authorities at the district government (approval no. 55.2-1-54-2532-34-2016 and 55.2-1-54-2532-123-2013 ). Mice were bred at the specific-pathogen free animal facility of Technical University of Munich. They had ad libitum access to food and water and were maintained at 22 ± 1 C and 50%-60% relative humidity in a 12 h:12 h light:dark cycle. Male 129S6/SvEv mice, aged 5 to 6 wk were used for primary cultures of brown and white adipocytes. Male C57BL/6J, male C57BL6/N mice, male 129S1/SvImJ mice (UCP1-KO mice and wild-type littermates) and male 129S6/SvEV were used for the in vivo experiments. Athymic female Nude-Foxn1 nu mice, aged 13 wk at the beginning of the experiments were obtained from Envigo and kept at 24 ± 1 C with ad libitum access to food and water at the Helmholtz Zentrum Mü nchen.
Primary cell culture
Adipose tissues were dissected from 5 week-old 129S6/SvEV mice or 129S1/SvImJ mice (UCP1-KO mice and wild-type littermates) (n = 2 per experiment, pooled) and digested with collagenase as described previously (Li et al., 2014) . Floating mature adipocytes were harvested for gene expression analysis. Stromal vascular fraction (SVF) cells were either harvested or plated in 12-well plates, and adherent cells were grown to confluence. Cells were differentiated into adipocytes as previously described. Briefly, cells were cultured for 2 days with 5 mg/ml insulin, 1 nM 3,3 0 ,5-triiodo-l-thyronine (T3), 125 mM indomethacin, 0.5 mM isobutylmethylxanthine (IBMX) and 1 mM dexamethasone in adipocyte culture media (DMEM supplemented with 10% heat-inactivated FBS, penicillin/streptomycin). Cells were then maintained in adipocyte culture media supplemented with 5 mg/ml insulin and 1 nM T3 for 6 days, with fresh media replacement every 2 days. Cells were harvested on day 7 with or without 6h secretin (500nM) treatment in TRISure.
Human study
Human experiments were performed in Turku PET Centre in Finland as part of two separate PET/CT imaging study cohorts. The ethical committee of South-Western Finland Hospital District evaluated and approved the studies, and all participants gave their written informed consent before any study procedures (Clinical trial number: NCT03290846).
Serum secretin levels were measured in seventeen healthy volunteers (13 females and 4 males; 36.3 ± 9.5 years; BMI 27.2 ± 2.9), who participated in a study where post-prandial BAT oxygen consumption and fatty acid uptake were measured using 15O-O2 and 18F-FTHA PET/CT, respectively. Blood samples for secretin measurement were drawn at baseline (overnight fasting) and 30-40 minutes after completing a mixed meal consisting of 542 kcal (58% carbohydrates, 25% fat, 17% protein). Concurrent dynamic PET imaging of supraclavicular and upper thoracic region was performed during postprandial state.
Effects of secretin on BAT glucose metabolism was evaluated in a separate group of lean, healthy males (n = 7, mean age 46.6 ± 11.9 years; mean BMI 23.7 ± 2.0). Studies were done twice, after two short intravenous infusions of secretin hydrochloride (Secrelux, 1IU/kg each) or saline (placebo) using single-blinded randomization. Dynamic PET-CT scans of the neck area, were done using 18F-FDG and analyzed as described earlier (Virtanen et al., 2009 ).
METHOD DETAILS
RNA-sequencing Total RNA isolated from BAT samples of male C57BL/6J mice (n = 4) housed under room temperature (23 C) was applied to transcriptome analysis by next generation sequencing (RNA-Seq) using Illumina HiSeq 2500 platform (Illumina). Sequencing libraries were prepared using the TruSeq RNA Sample Prep kit v2 (Illumina). Libraries from 4 samples were pooled into one sequencing lane and sequenced using a 50-cycle TruSeq SBS Kit v3-HS (Illumina), resulting in a depth of > 25 million reads/sample. Sequenced tags were aligned to the Ensembl 75 transcriptome annotation (NCBI38/mm10 mouse genome) using Genomatix Software Suite. All genes and transcripts were assigned relative coverage rates as measured in RPKM units ('reads per kilobase per million mapped reads').
Western Blot
For western blot analysis, cells were lysed in RIPA buffer. 30mg of total-cell lysates were separated on 12.5% SDS-PAGE gels, transferred to PVDF membrane (Millipore) by using a Trans-Blot SD. Semi-Dry Transfer Cell (Bio-Rad), and probed with anti-UCP1 (1:10,000), anti-ACTIN (Millipore, 1:10,000) and anti-SCTR (Sigma, 1:300). Secondary antibodies conjugated to IRDye 680 or IRDye 800 (Li-Cor Biosciences) were incubated at a dilution of 1:20,000. Fluorescent images were captured by an Odyssey fluorescent imager (Li-Cor Biosciences) .
Gene expression analysis (qRT-PCR)
RNA was extracted from cultured cells or frozen tissue samples (129S6/SvEV) using TRIsure, purified with SV Total RNA Isolation System, Promega and reverse transcribed using SensiFAST cDNA Synthesis Kit (BIOLINE). The resultant cDNA was analyzed by qRT-PCR. Briefly, 1 mL of 1:10 diuluted cDNA and 400 nmol of each primer were mixed with SensiMix SYBR Master Mix No-ROX (Bioline). Reactions were performed in 384-well format using a lightcycler II instrument (Roche). Standard reactions containing serial diluted pooled cDNA of all samples (Pure, 1:2, 1:4, 1:8, 1:16, 1:32 and 1:64) as a template were used to establish a standard curve, from which gene expression levels of samples were calculated. The RNA abundance of each gene was normalized to a housekeeping gene Gtf2b. The following primers were used:
Ucp1 
Respiration assays
The cellular oxygen consumption rate (OCR) of primary adipocytes was determined using an XF96 Extracellular Flux Analyzer (Seahorse Bioscience) as described previously (Li et al., 2014) . Briefly, primary adipocytes were cultured and differentiated in XF96 microplates. At day 7 of differentiation, cells were washed once with prewarmed, unbuffered assay medium (DMEM basal medium supplemented with 25 mM glucose, 31 mM NaCl, 2 mM GlutaMax and 15 mg/l phenol red, pH 7.4) (basal assay medium) and then the medium was replaced with basal assay medium containing 1%-2% essentially fatty acid free bovine serum albumin (BSA), and incubated at 37 C in a room air incubator for 1 h. The drug injections ports of the sensor cartridges were loaded with the assay reagents at 10X in basal assay medium (no BSA). Basal respiration was measured in untreated cells. Coupled respiration was inhibited by oligomycin treatment (5 mM). UCP1 mediated uncoupled respiration was determined after isoproterenol or secretin stimulation. Maximum respiratory capacity was assessed after FCCP (Sigma-Aldrich) addition (1 mM). Finally, mitochondrial respiration was blocked by antimycin A (Sigma-Aldrich) (5 mM) treatment and the residual OCR was considered non-mitochondrial respiration. For some experiments, cells were pretreated with 50mM H89 (PKA inhibitor), 1 -100 mM propranolol (b-adrenergic receptor antagonist), 40 mM Atglistatin (ATGL inhibitor) and 40 mM Hi76-0079 (HSL inhibitor), or reverse transfected with small interfering RNAs (siRNAs) targeting SctR (#1CCUGCUGAUCCCUCUCUUU; #2CCCUGUCCAACUUCAUCAA; #3CCAUCGUGAU CAAUUUCAU) and nontargeting control siRNA (UUUGUAAUCGUC GAUACCC) as described previously (Li et al., 2017 ) before bioenergetic profiling. Oxygen consumption rates were automatically calculated by the Seahorse XF-96 software. Each experiment was repeated at least 3 times with similar results.
Surgical implantation of telemetry transmitters
To monitor interscapular BAT temperature, telemetry transmitters (G2 E-Mitter, Starr Life Sciences Corp., Oakmont, PA, USA) were implanted above the interscapular BAT in 10-weeks-old 129S6/SvEv mice (n = 24). Mice were anesthetized by combined i.p. injection of medetomidine (0.5 mg/kg), midazolam (5 mg/kg) and fentanyl (0.05 mg/kg). The interscapular region was opened by a small incision and the transmitter was placed above the interscapular BAT pad. The incision was closed with surgical adhesive. Atipamezole (2.5 mg/kg), flumazenil (0.5 mg/kg) and naloxone (1.2 mg/kg) were injected subcutaneously to terminate anesthesia. In addition, mice received 10 mg/kg rimadyl and were singly housed in the post-operative recovery period for 4-5 days.
Monitoring of food intake and iBAT temperature Food intake (FI) was recorded in individually housed mice using an automated monitoring system (TSE LabMaster Home Cage Activity, Bad Homburg, Germany). The food baskets were connected to high precision balances to record FI. A receiver plate (ER4000 Energizer/Receiver, Oakmont, PA, USA) underneath the cage recorded interscapular BAT temperature (T iBAT ) signals of the implanted transmitter. Food basket weight and T iBAT were averaged in 5 min intervals. Mice were habituated to the cages with daily i.p. PBS injections for three days ahead of the experiment start, after which food was removed from the cages at 5pm and mice were fasted for overnight. In the next morning, mice were i.p. injected either PBS or secretin (5 nmol/mouse) and food intake was monitored during the following 72hs. For endogenous secretin blocking experiment, mice were s.c. injected with either anti-GFP or anti-secretin antibody at the time when food was removed. Postprandial secretin serum levels ( Figure. 3a) as well as in vitro testing results for blocking efficiency of the anti-secretin antibody (Phoenix Pharmaceuticals, G-067-04) ( Figure S5 ) were used to estimate the appropriate concentration of antibody to block endogenous secretin activity during refeeding. Assuming a total blood volume of 2 ml/mouse, 400 pmol anti-secretin antibody were injected per mouse. Propranolol (10mg/kg BW) or PBS was i.p. injected 20 min prior to secretin or PBS in the b-blockage experiment.
Indirect calorimetry
Indirect calorimetry was based on an open respirometer system (LabMaster System; TSE Systems, Bad Homburg, Germany) and was performed as described previously (Maurer et al., 2015) . Mice were placed in metabolic cages (3L volume) without food and water, transferred to a climate cabinet (TPK 600, Feutron, Greiz/Germany) preconditioned to 30 C and connected to the indirect calorimetry setup (Phenomaster, TSE Systems, Bad Homburg/Germany) to measure basal metabolic rate (BMR) during fasting (8:00 am-12:00 pm). The air from the cages was extracted over a period of 1 min every 7 min with a flow rate of 33 l/h, dried in a cooling trap and analyzed for O 2 content. O 2 consumption [ml/h] was calculated via comparison of the air from the cages with the air from an empty reference cage. BMR [ml O 2 /h] was calculated as the lowest mean of three consecutive oxygen consumption values. After BMR measurements, mice were i.p. injected either PBS or secretin (0.5mg/kg) and measured in the calorimetry chamber for about one hour with a high-resolution recording of 10 s intervals at 27 C to avoid secretin induced hyperthermia. Metabolic rates were converted into heat production (HP [mW] = (4.44+1.43*respiratory exchange ratio)*oxygen consumption [ml/h])).
Macroscopic multi-spectral optoacoustic tomography (MSOT) combined with indirect calorimetry Real-time multi-spectral optoacoustic tomography (MSOT) mouse measurements were conducted with an MSOT small animal imaging system (inVision 256-TF, iThera Medical GmbH, Munich, Germany) as described previously (Reber et al., 2018) . Athymic female Nude-Foxn1 nu mice were anesthetized by i.p. injection of 75 mg/kg pentobarbital (Narcoren, Merial GmbH, Germany) and placed in the MSOT system. To induce and image BAT activation, secretin (5 nmol) was administered via a catheter inserted in the mouse tail vein. Before, during, and after the activation period images were acquired at 25 different wavelengths: from 700 nm to 900 nm, with a step increment of 10 nm providing multi-spectral anatomic and functional information in a real-time and label-free mode. In parallel O 2 and CO 2 were analyzed in 1 s intervals using a transportable indirect calorimetry system (FoxBox, Sable Systems International, USA) and later converted into HP. For this compressed air from a bottle was pulled through the MSOT mouse holder with a flow rate of 700ml/min using the pump of the FoxBox. After the mouse holder air was dried by a cooling trap and magnesium perchlorate (Merck KGaA, Germany) and passing a filter (Model 9922-11, Parker Balston) before entering gas analysis. Gas composition of the empty mouse holder was analyzed before and after measuring the mouse and used for drift correction. Drift correction and data analysis was performed with the software ExpeData (ExpeData version 1.1.22, Sable Systems International, USA). HP before reflects the mean of the 5 min interval before injection and HP after the mean maximum HP in a 1 min interval measured after injection. The data analysis for MSOT measurements consisted of the calculation of the total blood volume (TBV = oxygenated hemoglobin (HbO 2 ) + deoxygenated hemoglobin (Hb)) and the oxygen saturation (SO 2 = HbO 2 /TBV).
Analysis of food intake data
Food intake was calculated as first derivative of cumulative food intake obtained from automated monitoring system (TSE LabMaster Home Cage Activity, Bad Homburg, Germany). Food intake greater than 0.005 g and separated by intermeal bout length greater or equal 15 min where defined as meal. Mean meal duration and mean intermeal bout length were calculated as mean of individual means.
Measurement of plasma secretin concentrations
Blood was collected at the time the mouse was killed. Plasma secretin levels were determined by ELISA using the kit purchased from Cloud-Clone following the manufacturer's instructions. Concentrations were calculated using a standard curve generated by secretin standards included in the kit.
Hypothalamic neuropeptides gene expression analysis
Male 129S1/SvImJ mice (UCP1 WT and KO) were fasted overnight and i.p. injected either PBS or secretin (5 nmol/mouse). After 4h of treatment, hypothalamic tissues were dissected, snap-frozen and later subjected to RNA extraction and gene expression analysis. In a second experiment, male 129S6/SvEV mice were fasted overnight and subsequently put into a climate chamber where they were exposed to room temperature or to moderate heat. In case of the heat exposure, environmental temperature has been raised from 34 C to 37 C with one degree per hour resulting in a total exposure time of 4 hours. Afterward hypothalamic tissue and preoptical region were separately dissected followed by the same procedure as in the previous experiment.
Diet-induced obese mice study All diet-induced obese (DIO) mice studies have been approved by Eli Lilly and Company's Institutional Animal Care and Use Committee.
Human secretin (1-27 amide: HSDGTFTSELSRLREGARLQRLLQGLV-amide; native secretin) and modified human secretin analog (1-27 amide: HSDGTFTSELSRLREE*ARLK*RLLQGLV-amide; modified secretin) (Dong et al., 2011) that contains a lactam bridge between side chains of Glu16 and Lys20 were synthesized by solid-phase peptide synthesis using established chemical protocols. After cleavage from the solid support and purification using reversed-phase chromatography, the lyophilized powders as trifluoroacetate salts were formulated in aqueous buffer.
Diet-induced obese (DIO) male C57BL6/N mice (Taconic Biosciences, Cambridge City, IN) 30 to 31 weeks old, maintained on a calorie rich diet since arrival at Lilly (TD95217; Teklad, Madison, WI), were used in the study. Mice were individually housed in a temperature-controlled (24 C) facility with 12 hour light/dark cycle (lights on 2200) and free access to food (TD95217) and water. After a minimum of 2 weeks acclimation to the facility, the mice were randomized according to their body weight, so each experimental group of animals would have similar body weight. The body weights ranged from 46 to 54 g. Vehicle (20 mM Citrate at pH 5.5), native secretin (166 nmol/kg/day) or modified secretin (163 nmol/kg/day) dissolved in vehicle was administered by subcutaneous (SC) mini-osmotic pump (Alzet, Model 2002; Durect Corporation, Cupertino, CA) as a SC infusion (12 ml/mouse/day) to ad libitum fed DIO mice throughout the study period. Body weight and food intake were monitored daily. Absolute changes in body weight were calculated by subtracting the body weight of the same animal on the first day of the treatment. On Days 1 and 14, total fat mass and total water mass were measured by quantitative nuclear magnetic resonance (QNMR) using an Echo Medical System (Houston, TX) instrument. Fat-free mass was calculated as body weight -fat mass. For the thermoneutral experiment, mice were acclimatized to 30 C one week before the experiment started. All other study conditions were kept, except the dosage. Native secretin was administered in a concentration of 996 nmol/kg/day and modified secretin of 326 nmol/kg/day. In addition to body weight and food intake, oxygen consumption was also measured.
Dual luciferase reporter assay
Blocking potential of the anti-secretin-antibody was determined by measuring secretin receptor activation in response to variable ratios of secretin and anti-secretin antibody. Secretin receptor activity was quantified using a dual luciferase reporter system based on cAMP response element (CRE) driven firefly luciferase (CRE-PLuc; Photinus pyralis) and constitutive Renilla luciferase (RLuc; Renilla reniformis). HEK293 cells were transiently transfected with CRE-PLuc, RLuc, and Sctr. Secretin receptor activity was quantified as the ratio of bioluminescence of firefly (PLuc) and renilla (RLuc) luciferase.
QUANTIFICATION AND STATISTICAL ANALYSIS
Two-tailed Student's t tests were used for single comparisons and analysis of variance (ANOVA) with Tukey's post hoc tests for multiple comparisons. PET/CT analysis was analyzed using paired one-tailed t test. P values below 0.05 were considered significant. Statistical analysis was performed with GraphPad prism 6 software. All data are represented as mean ± SD.
All linear mixed effect models were calculated with the fitlme function of MATLAB R2016b (Mathworks). Specifically, cumulative food intake was analyzed by means of linear mixed effect models with the fixed effects 'time' and 'treatment group', their interaction, and 'individual' as random effect. Additionally, we applied a more sophisticated model to specifically detect an effect of secretin on metabolic rate from cumulative food intake data by including the additional random factors 'initial body mass' (to capture the metabolic requirements of the mouse) and 'overall change in body mass' (to capture the alternate fate of food, i.e., fat deposition/loss).
DATA AND SOFWARE AVAILABILITY
The accession number for the RNA-Seq data presented in this article is GEO: GSE119452. and UCP1 À/À (orange) mice. Data are presented as mean ± SD (n = 12). (A-C) Vehicle (20mM Citrate), native secretin (166 nmol/kg/day), modified secretin (163 nmol/kg/day) or GLP1 analog (CEX51, 30 nmol/kg/day) dissolved in vehicle was administered by subcutaneous (s.c.) miniosmotic pumps as a s.c. infusion (12ml/mouse/day) to ad libitum fed diet-induced obese (DIO) male C57BL6/ N mice throughout the study period (n = 6). Mice were kept at room temperature. (A) Food intake and (B) body weight were monitored daily. Absolute changes in body weight were calculated by subtracting the body weight of the same animal on the first day of treatment. (C) On day 1 and 14, total fat mass and total water mass were measured by quantitative nuclear magnetic resonance (QNMR). Fat-free mass was calculated as body weight minus fat mass. (D) Two-bolus Secrelux infusion increases serum secretin level in humans. Representative time course of serum secretin level after two-bolus Secrelux infusion (0 min and 15 min). The second Secrelux bolus was administered right after [
18 F]-FDG injection. Subsequently, PET scanning of the cervical region was initiated and glucose uptake was measured for approximately 40 min. (A) was analyzed by linear mixed effects model with fixed effects ''treatment,'' ''time'' and interaction between both and with random factor ''individual.'' (B) was analyzed by two-way ANOVA RM (Tukey's test). (C) was analyzed by one-way ANOVA (Tukey's test). * = p < 0.05; ** = p < 0.01, *** = p < 0.001.
